(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer complications, a propensity-matched cohort study showed.
The retrospective…
Source link : https://www.medpagetoday.com/meetingcoverage/ascogi/119431
Author :
Publish date : 2026-01-14 20:43:00
Copyright for syndicated content belongs to the linked Source.









